Rani Therapeutics Holdings (RANI) Leases (2022 - 2025)
Historic Leases for Rani Therapeutics Holdings (RANI) over the last 4 years, with Q3 2025 value amounting to $4.0 million.
- Rani Therapeutics Holdings' Leases fell 2598.12% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 2598.12%. This contributed to the annual value of $5.1 million for FY2024, which is 60974.93% up from last year.
- Rani Therapeutics Holdings' Leases amounted to $4.0 million in Q3 2025, which was down 2598.12% from $4.4 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Leases ranged from a high of $6.0 million in Q1 2024 and a low of $718000.0 during Q4 2023
- Moreover, its 4-year median value for Leases was $1.4 million (2023), whereas its average is $2.9 million.
- In the last 5 years, Rani Therapeutics Holdings' Leases tumbled by 3258.22% in 2023 and then soared by 60974.93% in 2024.
- Rani Therapeutics Holdings' Leases (Quarter) stood at $1.1 million in 2022, then tumbled by 32.58% to $718000.0 in 2023, then soared by 609.75% to $5.1 million in 2024, then fell by 21.17% to $4.0 million in 2025.
- Its Leases stands at $4.0 million for Q3 2025, versus $4.4 million for Q2 2025 and $4.7 million for Q1 2025.